Association of Admission Blood Glucose Level with Major Adverse Cardiac Events in Acute Coronary Syndrome; a Cohort Study
Introduction: Appropriate management of abnormal admission blood glucose level (ABGL) in acute coronary syndrome (ACS) patients still remains a common issue. This study aims to assess the influence of ABGL on development of 30-day major adverse cardiac events (MACEs) in patients with suspected ACS....
Main Authors: | Mostafa Alavi-Moghaddam, Mohammad Parsa-Mahjoub, Robabeh Ghodssi-ghassemabadi, Bita Bitazar |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2019-04-01
|
Series: | Archives of Academic Emergency Medicine |
Subjects: | |
Online Access: | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/316 |
Similar Items
-
Elevated Glucose on Admission Was an Independent Risk Factor for 30-Day Major Adverse Cardiovascular Events in Patients with STEMI but Not NSTEMI
by: Linlin Ma, et al.
Published: (2024-01-01) -
Association between admission blood glucose and prognosis in non-diabetic patients with first-ever acute myocardial infarction
by: Eskandari Ramin, et al.
Published: (2022-03-01) -
Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
by: Hossein Farshidi, et al.
Published: (2018-02-01) -
Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia
by: Zhongxing Cai, et al.
Published: (2021-12-01) -
Relationship of Admission Glucose level with No-Reflow or Slow Flow in STEMI patients Undergoing Primary Percutaneous Coronary Intervention
by: Junaid Arshad, et al.
Published: (2023-12-01)